The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR

By sjmartinez • August 5, 2022

Steffen J, Ngo J, Wang SP, Williams K, Kramer HF, Ho G, Rodriguez C, Yekkala K, Amuzie C, Bialecki R, Norquay L, Nawrocki AR, Erion M, Pocai A, Shirihai OS, Liesa M. The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR. Mol Metab. 2022 Aug 5:101566. doi: 10.1016/j.molmet.2022.101566. Epub ahead of print. PMID: 35940556.

Tags: ATF4, Drp1, Endocrinology, ISR, mitochondria, NASH, Oma1, Publications

Efficacy and safety of relacorilant for the treatment of patients with Cushing’s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Pivonello R, Arnaldi G, Auchus RJ, Badiu C, Busch RS, Cannavò S, Dischinger U, Dobri GA, Donegan DM, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno[...]

Stephanie Smooke Praw, MD Appointed Interim Chief of the UCLA Division of Endocrinology

The UCLA Department of Medicine is delighted to announce that Stephanie Smooke Praw, MD has been appointed interim chief of the UCLA Division of Endocrinology, expanding upon her[...]

Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions

Pahulu I, Calumpit M, Tominez P, Shih JJ, Ebrahimi S, Deville NV, Samoa R, Moin T, Sedrak MS, Valle LF, Steinberg M, Kishan AU, Ganz[...]